TOP TIERMARKET NEWSWIRE
News & sentiment

AKARI THERAPEUTICS P ADR (AKTX) — News & AI sentiment

AKARI THERAPEUTICS P ADR (AKTX) news roundup. 9 stories aggregated over the last 30 days. Average 30-day sentiment is 57.7/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
9
avg sentiment 57.7/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

AKTX news in the last 24 hours, 7 days, 30 days and 90 days

How much AKTX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowAKTX storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days957.7/100AKTX headlines →
Last 90 days2058.6/100AKTX headlines →

Latest stories on AKTX

Oct 15
Oct 15
Oct 14
Oct 13
Oct 13
Oct 13
Akari Therapeutics Plc (AKTX) files 8-K
SEC 8-K50 · neutralgeneral
Oct 1
Oct 1
Oct 1
Sep 8
Sep 8
Aug 27
Aug 18
Aug 18
Aug 18
Akari Therapeutics reports Q2 results
Seeking Alpha50 · neutralearnings
Aug 14
Aug 13
Aug 13
Akari Therapeutics Plc (AKTX) files 8-K
SEC 8-K50 · neutralgeneral
Aug 13
Aug 4
Jul 23
Jul 22
Jul 21
Jul 13
Jul 7
Open AKTX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →